| 768348 |
FRONTIERS IN ONCOLOGY |
Successful Treatment of an Elderly Patient With Combined Small Cell Lung Cancer Receiving Anlotinib: A Case Report |
2021-11-11 |
10.3389/fonc.2021.775201 |
Gan Yuying, Liu Pingli, Luo Tao |
| 768347 |
FRONTIERS IN ONCOLOGY |
Navigation-Guided Transnasal Endoscopic Delineation of the Posterior Margin for Maxillary Sinus Cancers: A Preclinical Study |
2021-11-11 |
10.3389/fonc.2021.747227 |
Taboni Stefano, Ferrari Marco, Daly Michael J., Chan Harley H. L., Eu Donovan, Gualtieri Tommaso, Jethwa Ashok R., Sahovaler Axel, Sewell Andrew, Hasan Wael, Berania Ilyes, Qiu Jimmy, de Almeida John, Nicolai Piero, Gilbert Ralph W., Irish Jonathan C. |
| 768346 |
FRONTIERS IN ONCOLOGY |
Hypermethylation of the Promoter of miR-338-5p Mediates Aberrant Expression of ETS-1 and Is Correlated With Disease Severity Of Astrocytoma Patients |
2021-11-11 |
10.3389/fonc.2021.773644 |
Wang Junping, Huo Cheng, Yin Jinzhu, Tian Lixia, Ma Lili, Wang Dongsheng |
| 768345 |
FRONTIERS IN ONCOLOGY |
Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients |
2021-11-11 |
10.3389/fonc.2021.774088 |
Radziuviene Gedmante, Rasmusson Allan, Augulis Renaldas, Grineviciute Ruta Barbora, Zilenaite Dovile, Laurinaviciene Aida, Ostapenko Valerijus, Laurinavicius Arvydas |
| 768344 |
FRONTIERS IN ONCOLOGY |
Multiomics Landscape Uncovers the Molecular Mechanism of the Malignant Evolution of Lung Adenocarcinoma Cells to Chronic Low Dose Cadmium Exposure |
2021-11-11 |
10.3389/fonc.2021.654687 |
Dai Shun-Dong, Wang Shuang, Qin Ya-Nan, Zhu Jin-Chao |
| 768343 |
FRONTIERS IN ONCOLOGY |
Long-Term Efficacy of Neoadjuvant Concurrent Chemoradiotherapy for Potentially Resectable Advanced Siewert Type II and III Adenocarcinomas of the Esophagogastric Junction |
2021-11-11 |
10.3389/fonc.2021.756440 |
Tian Yuan, Wang Jun, Qiao Xueying, Zhang Jun, Li Yong, Fan Liqiao, Zhang Zhidong, Zhao Xuefeng, Tan Bibo, Wang Dong, Yang Peigang, Zhao Qun |
| 768342 |
FRONTIERS IN ONCOLOGY |
Elevated DNA Polymerase Delta 1 Expression Correlates With Tumor Progression and Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma |
2021-11-11 |
10.3389/fonc.2021.736363 |
Zhao Shuai, Wei Cuicui, Tang Haijia, Ding Han, Han Bing, Chen Shuxian, Song Xiaoling, Gu Qiang, Zhang Yichi, Liu Wangrui, Wang Jian |
| 768341 |
FRONTIERS IN ONCOLOGY |
Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value |
2021-11-11 |
10.3389/fonc.2021.780654 |
Najem Ahmad, Wouters Jasper, Krayem Mohammad, Rambow Florian, Sabbah Malak, Sales François, Awada Ahmad, Aerts Stein, Journe Fabrice, Marine Jean-Christophe, Ghanem Ghanem E. |
| 768340 |
FRONTIERS IN ONCOLOGY |
Low Ligation Plus High Dissection Versus High Ligation of the Inferior Mesenteric Artery in Sigmoid Colon and Rectal Cancer Surgery: A Meta-Analysis |
2021-11-11 |
10.3389/fonc.2021.774782 |
Yin Tzu-Chieh, Chen Yen-Cheng, Su Wei-Chih, Chen Po-Jung, Chang Tsung-Kun, Huang Ching-Wen, Tsai Hsiang-Lin, Wang Jaw-Yuan |
| 768339 |
FRONTIERS IN ONCOLOGY |
Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis |
2021-11-11 |
10.3389/fonc.2021.746976 |
Chen Xiuqiong, Meng Fanqiao, Jiang Richeng |
